Ajay Bhatia

Statistics

Publications

Citations

216

H-Index

Active since

2015

Affiliations

Amgen (United States)(Current)

Hospital Israelita Albert Einstein

University of the Witwatersrand

Université du Québec à Chicoutimi

University Hospital of Geneva

Ajay Bhatia is an author at Amgen (United States) specializing in cardiovascular pharmacotherapy, clinical pharmacology, and familial hypercholesterolemia.

Publications per year

2015–2025

Publications

Evolocumab in Patients without a Previous Myocardial Infarction or Stroke

Erin A. Bohula, Nicholas Marston, Ajay Bhatia et al. · New England Journal of Medicine · 2025 · 66 citations

Medicine, Pharmacology, Pharmacotherapy +17

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh et al. · The Lancet Diabetes & Endocrinology · 2022 · 48 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +10

Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial

Erin A. Bohula, Nicholas Marston, Andrea Ruzza et al. · American Heart Journal · 2023 · 31 citations

Medicine, Cardiology, Internal Medicine +12

Detection of blur artifacts in histopathological whole-slide images of endomyocardial biopsies

Hang Wu, John H. Phan, Ajay Bhatia et al. · 2015 · 28 citations

Medicine, Biomedical Engineering, Pathology +17

Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies

Frederick J. Raal, Robert A. Hegele, Andrea Ruzza et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2024 · 20 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17

1–5 of 7